Medtronic to Buy Contego Medical for $380 Million, Days After FDA Approves Its Carotid System
Medtronic plans to buy Contego Medical for $380 million plus undisclosed contingent payments. The deal adds a carotid stenting system with a built-in filter that the FDA approved days earlier, setting up direct competition with Boston Scientific in the growing field of transcarotid revascularization.
FDA Approves InspireMD’s CGuard Prime for TCAR, Six Months After a Delivery-System Recall
InspireMD has won FDA approval to use its CGuard Prime carotid stent in TCAR procedures, months after recalling the device's transfemoral delivery system. The pivotal study enrolled 50 patients with no comparison group, and the company has flagged substantial doubt about its ability to continue operating.